Physician profile
Pedro Rodriguez
NPI 1881889194
$28,281.44
in general payments reported to CMS, 2019-2025
13 companies · $577 in 2025
The $577 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $11K · 2021: $1,564 · 2022: $145 · 2023: $93.41 · 2024: $111 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $525 · Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $524.96 |
| Food and Beverage | $255.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $24,361.45 | 2019-2020 | |
| Allergan, INC. | $1,823.98 | 2019-2021 | |
| Musculoskeletal Transplant Foundation INC. | $834.12 | 2019-2025 | |
| Arteriocyte Medical Systems, INC. | $801.52 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $155.32 | 2023-2025 | Caplyta |
| Medline Industries LP | $75.04 | 2019 | |
| Livanova USA, INC. | $73.58 | 2023 | Vns Therapy Symmetry Model 8103 Generator |
| Mentor Worldwide LLC | $50.53 | 2021 | |
| Kci USA, INC. | $32.23 | 2019 | |
| Kerecis Limited | $27.09 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Orthofix Medical, INC. | $22.20 | 2022 | |
| Medtronic USA, INC. | $13.32 | 2020 | |
| Smith+Nephew, INC. | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pedro Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.